As many of my colleagues have mentioned, I was surprised to read the article (Raskind et. al, 2018) and find that the results showed no benefit from prazosin vs placebo in helping with nightmares. From years of experience working at a VA, it was a given that prazosin helped with PTSD related nightmares. I felt surprisingly defensive at the results. I found myself questioning the results, rereading the article to look for how the study was not valid or generalizable. One notable point was that it was not representative of acute PTSD-- that the population was fairly stable. The authors noted that prescribers may have prescribed prazosin for their more acute patients and so the responders could be the more acute patients. And of course, the exclusion criteria really limits the generalizability of this study: no other comorbid psychiatric diagnoses, no SI/HI, no substance use. In addition, the group consisted of mostly men, and military related PTSD as a diagnosis. I really appreciated our journal club discussion, and how we went through the article to really address any potential biases, omissions, or other potential red flags. Coming out of the journal club, I was reflecting on whether this would alter my prescribing practice and change how prazosin may be a go to drug for PTSD related nightmares. At this point, without further studies, I don’t think it will. Most patients I will see will likely not fit this demographic, so this may not apply. Even among a Veteran population, most patients seeking MH care for nightmares may also not fit into this population. It will, however, add some hesitation and skepticism on my part, which I believe I will need to be cautious of when advocating and explaining this medication to a patient when offering them hope for relief.
Something that I have been continue to think about, though, is my initial reaction to the results, and the skepticism I had. I thought about how for me personally, if I don’t agree with the results, I look harder to find ways that the study is invalid or not generalizable. If I do agree with the results, I may be less likely to comb through each part with a fine-tooth comb. All the more reason to get better practice at reading articles with a more critical eye all of the time, so that it becomes my baseline for how to read a research article. Thanks for a good discussion, all.
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Homes, K. L., . . . Huang, G. D. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. The New England Journal of Medicine, 378(6): 507-517.